Long-Fei Yue, MD, Chief Doctor, Department of General Practice, People’s Hospital of Anshun, No. 140 Huangguoshu Street, Anshun 561000, Guizhou Province, China. longfei_yue@163.com
Research Domain of This Article
Surgery
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Xian-Da Chai, Huan Jiang, Ling-Ling Tang, Jing Zhang, Department of Oral and Maxillofacial Surgery, People’s Hospital of Anshun, Anshun 561000, Guizhou Province, China
Long-Fei Yue, Department of General Practice, People’s Hospital of Anshun, Anshun 561000, Guizhou Province, China
Author contributions: Chai XD and Yue LF designed the study, analyzed the data and prepared the manuscript; Jiang H, Tang LL and Zhang J collected the data; Chai XD interpreted the data; All authors have read and approved the manuscript.
Institutional review board statement: The study was reviewed and approved by the Anshun People's Hospital Ethics Committee (Approval No. 3).
Informed consent statement: The patient provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors declare no conflict-of-interest.
Data sharing statement: Technical appendix, statistical code, and dataset available from the corresponding author at email lonhfei_yue@163.com. Participants gave informed consent for data.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Long-Fei Yue, MD, Chief Doctor, Department of General Practice, People’s Hospital of Anshun, No. 140 Huangguoshu Street, Anshun 561000, Guizhou Province, China. longfei_yue@163.com
Received: November 2, 2023 Peer-review started: November 2, 2023 First decision: January 9, 2024 Revised: January 22, 2024 Accepted: February 25, 2024 Article in press: February 25, 2024 Published online: March 26, 2024
Abstract
BACKGROUND
Frey syndrome, also known as ototemporal nerve syndrome or gustatory sweating syndrome, is one of the most common complications of parotid gland surgery. This condition is characterized by abnormal sensations in the facial skin accompanied by episodes of flushing and sweating triggered by cognitive processes, visual stimuli, or eating.
AIM
To investigate the preventive effect of acellular dermal matrix (ADM) on Frey syndrome after parotid tumor resection and analyzed the effects of Frey syndrome across various surgical methods and other factors involved in parotid tumor resection.
METHODS
Retrospective data from 82 patients were analyzed to assess the correlation between sex, age, resection sample size, operation time, operation mode, ADM usage, and occurrence of postoperative Frey syndrome.
RESULTS
Among the 82 patients, the incidence of Frey syndrome was 56.1%. There were no significant differences in sex, age, or operation time between the two groups (P > 0.05). However, there was a significant difference between ADM implantation and occurrence of Frey syndrome (P < 0.05). ADM application could reduce the variation in the incidence of Frey syndrome across different operation modes.
CONCLUSION
ADM can effectively prevent Frey syndrome and delay its onset.
Core Tip: The use of acellular dermal matrix in parotid tumor surgery can reduce the incidence of Frey syndrome, especially when the diameter of the surgically removed parotid tissue is greater than 4 cm.
